Global In Vitro Assays to Diagnose Infectious Diseases Supply, Demand and Key Producers, 2023-2029
The global In Vitro Assays to Diagnose Infectious Diseases market size is expected to reach $ 3320.3 million by 2029, rising at a market growth of -1.3% CAGR during the forecast period (2023-2029).
Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a highly sensitive and specific assay that detects the presence of antigens or antibodies in patient samples. ELISA can be used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and Lyme disease.
In Vitro Assays to Diagnose Infectious Diseases market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.
This report studies the global In Vitro Assays to Diagnose Infectious Diseases demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for In Vitro Assays to Diagnose Infectious Diseases, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of In Vitro Assays to Diagnose Infectious Diseases that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global In Vitro Assays to Diagnose Infectious Diseases total market, 2018-2029, (USD Million)
Global In Vitro Assays to Diagnose Infectious Diseases total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: In Vitro Assays to Diagnose Infectious Diseases total market, key domestic companies and share, (USD Million)
Global In Vitro Assays to Diagnose Infectious Diseases revenue by player and market share 2018-2023, (USD Million)
Global In Vitro Assays to Diagnose Infectious Diseases total market by Type, CAGR, 2018-2029, (USD Million)
Global In Vitro Assays to Diagnose Infectious Diseases total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global In Vitro Assays to Diagnose Infectious Diseases market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QIAGEN, BD, bioMerieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp.?, iemens Healthineers AG and Bio-Rad Laboratories, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World In Vitro Assays to Diagnose Infectious Diseases market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global In Vitro Assays to Diagnose Infectious Diseases Market, By Region:
1. How big is the global In Vitro Assays to Diagnose Infectious Diseases market?
2. What is the demand of the global In Vitro Assays to Diagnose Infectious Diseases market?
3. What is the year over year growth of the global In Vitro Assays to Diagnose Infectious Diseases market?
4. What is the total value of the global In Vitro Assays to Diagnose Infectious Diseases market?
5. Who are the major players in the global In Vitro Assays to Diagnose Infectious Diseases market?
6. What are the growth factors driving the market demand?
Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a highly sensitive and specific assay that detects the presence of antigens or antibodies in patient samples. ELISA can be used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and Lyme disease.
In Vitro Assays to Diagnose Infectious Diseases market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.
This report studies the global In Vitro Assays to Diagnose Infectious Diseases demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for In Vitro Assays to Diagnose Infectious Diseases, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of In Vitro Assays to Diagnose Infectious Diseases that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global In Vitro Assays to Diagnose Infectious Diseases total market, 2018-2029, (USD Million)
Global In Vitro Assays to Diagnose Infectious Diseases total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: In Vitro Assays to Diagnose Infectious Diseases total market, key domestic companies and share, (USD Million)
Global In Vitro Assays to Diagnose Infectious Diseases revenue by player and market share 2018-2023, (USD Million)
Global In Vitro Assays to Diagnose Infectious Diseases total market by Type, CAGR, 2018-2029, (USD Million)
Global In Vitro Assays to Diagnose Infectious Diseases total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global In Vitro Assays to Diagnose Infectious Diseases market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QIAGEN, BD, bioMerieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp.?, iemens Healthineers AG and Bio-Rad Laboratories, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World In Vitro Assays to Diagnose Infectious Diseases market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global In Vitro Assays to Diagnose Infectious Diseases Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immunoassay
- Molecular Diagnosis
- Others
- Streptococcus
- Clostridium Difficile
- Candida
- Tuberculosis
- Others
- QIAGEN
- BD
- bioMerieux SA
- F. Hoffmann-La Roche, Ltd.
- Hologic, Inc. (Gen-Probe)
- Abbott
- Quidel Corp.?
- iemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Danaher Corp.
- OraSure Technologies, Inc
1. How big is the global In Vitro Assays to Diagnose Infectious Diseases market?
2. What is the demand of the global In Vitro Assays to Diagnose Infectious Diseases market?
3. What is the year over year growth of the global In Vitro Assays to Diagnose Infectious Diseases market?
4. What is the total value of the global In Vitro Assays to Diagnose Infectious Diseases market?
5. Who are the major players in the global In Vitro Assays to Diagnose Infectious Diseases market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 In Vitro Assays to Diagnose Infectious Diseases Introduction
1.2 World In Vitro Assays to Diagnose Infectious Diseases Market Size & Forecast (2018 & 2022 & 2029)
1.3 World In Vitro Assays to Diagnose Infectious Diseases Total Market by Region (by Headquarter Location)
1.3.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.3 China In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.4 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.5 Japan In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.6 South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.7 ASEAN In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.8 India In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 In Vitro Assays to Diagnose Infectious Diseases Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 In Vitro Assays to Diagnose Infectious Diseases Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.2 World In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Region
2.2.1 World In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Region (2018-2023)
2.2.2 World In Vitro Assays to Diagnose Infectious Diseases Consumption Value Forecast by Region (2024-2029)
2.3 United States In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.4 China In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.5 Europe In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.6 Japan In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.7 South Korea In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.8 ASEAN In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.9 India In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
3 WORLD IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES COMPANIES COMPETITIVE ANALYSIS
3.1 World In Vitro Assays to Diagnose Infectious Diseases Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for In Vitro Assays to Diagnose Infectious Diseases in 2022
3.2.3 Global Concentration Ratios (CR8) for In Vitro Assays to Diagnose Infectious Diseases in 2022
3.3 In Vitro Assays to Diagnose Infectious Diseases Company Evaluation Quadrant
3.4 In Vitro Assays to Diagnose Infectious Diseases Market: Overall Company Footprint Analysis
3.4.1 In Vitro Assays to Diagnose Infectious Diseases Market: Region Footprint
3.4.2 In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Type Footprint
3.4.3 In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: In Vitro Assays to Diagnose Infectious Diseases Consumption Value Comparison
4.2.1 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based In Vitro Assays to Diagnose Infectious Diseases Companies and Market Share, 2018-2023
4.3.1 United States Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (States, Country)
4.3.2 United States Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023)
4.4 China Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue and Market Share, 2018-2023
4.4.1 China Based In Vitro Assays to Diagnose Infectious Diseases Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023)
4.5 Rest of World Based In Vitro Assays to Diagnose Infectious Diseases Companies and Market Share, 2018-2023
4.5.1 Rest of World Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immunoassay
5.2.2 Molecular Diagnosis
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2018-2023)
5.3.2 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2024-2029)
5.3.3 World In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Streptococcus
6.2.2 Clostridium Difficile
6.2.3 Candida
6.2.4 Tuberculosis
6.2.5 Tuberculosis
6.3 Market Segment by Application
6.3.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2018-2023)
6.3.2 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2024-2029)
6.3.3 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 QIAGEN
7.1.1 QIAGEN Details
7.1.2 QIAGEN Major Business
7.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.1.4 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 QIAGEN Recent Developments/Updates
7.1.6 QIAGEN Competitive Strengths & Weaknesses
7.2 BD
7.2.1 BD Details
7.2.2 BD Major Business
7.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.2.4 BD In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 BD Recent Developments/Updates
7.2.6 BD Competitive Strengths & Weaknesses
7.3 bioMerieux SA
7.3.1 bioMerieux SA Details
7.3.2 bioMerieux SA Major Business
7.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.3.4 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 bioMerieux SA Recent Developments/Updates
7.3.6 bioMerieux SA Competitive Strengths & Weaknesses
7.4 F. Hoffmann-La Roche, Ltd.
7.4.1 F. Hoffmann-La Roche, Ltd. Details
7.4.2 F. Hoffmann-La Roche, Ltd. Major Business
7.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.4.4 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 F. Hoffmann-La Roche, Ltd. Recent Developments/Updates
7.4.6 F. Hoffmann-La Roche, Ltd. Competitive Strengths & Weaknesses
7.5 Hologic, Inc. (Gen-Probe)
7.5.1 Hologic, Inc. (Gen-Probe) Details
7.5.2 Hologic, Inc. (Gen-Probe) Major Business
7.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.5.4 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Hologic, Inc. (Gen-Probe) Recent Developments/Updates
7.5.6 Hologic, Inc. (Gen-Probe) Competitive Strengths & Weaknesses
7.6 Abbott
7.6.1 Abbott Details
7.6.2 Abbott Major Business
7.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.6.4 Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Abbott Recent Developments/Updates
7.6.6 Abbott Competitive Strengths & Weaknesses
7.7 Quidel Corp.?
7.7.1 Quidel Corp.? Details
7.7.2 Quidel Corp.? Major Business
7.7.3 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.7.4 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Quidel Corp.? Recent Developments/Updates
7.7.6 Quidel Corp.? Competitive Strengths & Weaknesses
7.8 iemens Healthineers AG
7.8.1 iemens Healthineers AG Details
7.8.2 iemens Healthineers AG Major Business
7.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.8.4 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 iemens Healthineers AG Recent Developments/Updates
7.8.6 iemens Healthineers AG Competitive Strengths & Weaknesses
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Bio-Rad Laboratories, Inc. Details
7.9.2 Bio-Rad Laboratories, Inc. Major Business
7.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.9.4 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
7.9.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
7.10 Danaher Corp.
7.10.1 Danaher Corp. Details
7.10.2 Danaher Corp. Major Business
7.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.10.4 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Danaher Corp. Recent Developments/Updates
7.10.6 Danaher Corp. Competitive Strengths & Weaknesses
7.11 OraSure Technologies, Inc
7.11.1 OraSure Technologies, Inc Details
7.11.2 OraSure Technologies, Inc Major Business
7.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.11.4 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 OraSure Technologies, Inc Recent Developments/Updates
7.11.6 OraSure Technologies, Inc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 In Vitro Assays to Diagnose Infectious Diseases Industry Chain
8.2 In Vitro Assays to Diagnose Infectious Diseases Upstream Analysis
8.3 In Vitro Assays to Diagnose Infectious Diseases Midstream Analysis
8.4 In Vitro Assays to Diagnose Infectious Diseases Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 In Vitro Assays to Diagnose Infectious Diseases Introduction
1.2 World In Vitro Assays to Diagnose Infectious Diseases Market Size & Forecast (2018 & 2022 & 2029)
1.3 World In Vitro Assays to Diagnose Infectious Diseases Total Market by Region (by Headquarter Location)
1.3.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.3 China In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.4 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.5 Japan In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.6 South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.7 ASEAN In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.3.8 India In Vitro Assays to Diagnose Infectious Diseases Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 In Vitro Assays to Diagnose Infectious Diseases Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 In Vitro Assays to Diagnose Infectious Diseases Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.2 World In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Region
2.2.1 World In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Region (2018-2023)
2.2.2 World In Vitro Assays to Diagnose Infectious Diseases Consumption Value Forecast by Region (2024-2029)
2.3 United States In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.4 China In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.5 Europe In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.6 Japan In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.7 South Korea In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.8 ASEAN In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
2.9 India In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029)
3 WORLD IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES COMPANIES COMPETITIVE ANALYSIS
3.1 World In Vitro Assays to Diagnose Infectious Diseases Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for In Vitro Assays to Diagnose Infectious Diseases in 2022
3.2.3 Global Concentration Ratios (CR8) for In Vitro Assays to Diagnose Infectious Diseases in 2022
3.3 In Vitro Assays to Diagnose Infectious Diseases Company Evaluation Quadrant
3.4 In Vitro Assays to Diagnose Infectious Diseases Market: Overall Company Footprint Analysis
3.4.1 In Vitro Assays to Diagnose Infectious Diseases Market: Region Footprint
3.4.2 In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Type Footprint
3.4.3 In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: In Vitro Assays to Diagnose Infectious Diseases Consumption Value Comparison
4.2.1 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: In Vitro Assays to Diagnose Infectious Diseases Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based In Vitro Assays to Diagnose Infectious Diseases Companies and Market Share, 2018-2023
4.3.1 United States Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (States, Country)
4.3.2 United States Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023)
4.4 China Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue and Market Share, 2018-2023
4.4.1 China Based In Vitro Assays to Diagnose Infectious Diseases Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023)
4.5 Rest of World Based In Vitro Assays to Diagnose Infectious Diseases Companies and Market Share, 2018-2023
4.5.1 Rest of World Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immunoassay
5.2.2 Molecular Diagnosis
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2018-2023)
5.3.2 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2024-2029)
5.3.3 World In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Streptococcus
6.2.2 Clostridium Difficile
6.2.3 Candida
6.2.4 Tuberculosis
6.2.5 Tuberculosis
6.3 Market Segment by Application
6.3.1 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2018-2023)
6.3.2 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2024-2029)
6.3.3 World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 QIAGEN
7.1.1 QIAGEN Details
7.1.2 QIAGEN Major Business
7.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.1.4 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 QIAGEN Recent Developments/Updates
7.1.6 QIAGEN Competitive Strengths & Weaknesses
7.2 BD
7.2.1 BD Details
7.2.2 BD Major Business
7.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.2.4 BD In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 BD Recent Developments/Updates
7.2.6 BD Competitive Strengths & Weaknesses
7.3 bioMerieux SA
7.3.1 bioMerieux SA Details
7.3.2 bioMerieux SA Major Business
7.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.3.4 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 bioMerieux SA Recent Developments/Updates
7.3.6 bioMerieux SA Competitive Strengths & Weaknesses
7.4 F. Hoffmann-La Roche, Ltd.
7.4.1 F. Hoffmann-La Roche, Ltd. Details
7.4.2 F. Hoffmann-La Roche, Ltd. Major Business
7.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.4.4 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 F. Hoffmann-La Roche, Ltd. Recent Developments/Updates
7.4.6 F. Hoffmann-La Roche, Ltd. Competitive Strengths & Weaknesses
7.5 Hologic, Inc. (Gen-Probe)
7.5.1 Hologic, Inc. (Gen-Probe) Details
7.5.2 Hologic, Inc. (Gen-Probe) Major Business
7.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.5.4 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Hologic, Inc. (Gen-Probe) Recent Developments/Updates
7.5.6 Hologic, Inc. (Gen-Probe) Competitive Strengths & Weaknesses
7.6 Abbott
7.6.1 Abbott Details
7.6.2 Abbott Major Business
7.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.6.4 Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Abbott Recent Developments/Updates
7.6.6 Abbott Competitive Strengths & Weaknesses
7.7 Quidel Corp.?
7.7.1 Quidel Corp.? Details
7.7.2 Quidel Corp.? Major Business
7.7.3 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.7.4 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Quidel Corp.? Recent Developments/Updates
7.7.6 Quidel Corp.? Competitive Strengths & Weaknesses
7.8 iemens Healthineers AG
7.8.1 iemens Healthineers AG Details
7.8.2 iemens Healthineers AG Major Business
7.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.8.4 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 iemens Healthineers AG Recent Developments/Updates
7.8.6 iemens Healthineers AG Competitive Strengths & Weaknesses
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Bio-Rad Laboratories, Inc. Details
7.9.2 Bio-Rad Laboratories, Inc. Major Business
7.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.9.4 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
7.9.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
7.10 Danaher Corp.
7.10.1 Danaher Corp. Details
7.10.2 Danaher Corp. Major Business
7.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.10.4 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Danaher Corp. Recent Developments/Updates
7.10.6 Danaher Corp. Competitive Strengths & Weaknesses
7.11 OraSure Technologies, Inc
7.11.1 OraSure Technologies, Inc Details
7.11.2 OraSure Technologies, Inc Major Business
7.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product and Services
7.11.4 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 OraSure Technologies, Inc Recent Developments/Updates
7.11.6 OraSure Technologies, Inc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 In Vitro Assays to Diagnose Infectious Diseases Industry Chain
8.2 In Vitro Assays to Diagnose Infectious Diseases Upstream Analysis
8.3 In Vitro Assays to Diagnose Infectious Diseases Midstream Analysis
8.4 In Vitro Assays to Diagnose Infectious Diseases Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World In Vitro Assays to Diagnose Infectious Diseases Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World In Vitro Assays to Diagnose Infectious Diseases Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World In Vitro Assays to Diagnose Infectious Diseases Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World In Vitro Assays to Diagnose Infectious Diseases Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key In Vitro Assays to Diagnose Infectious Diseases Players in 2022
Table 12. World In Vitro Assays to Diagnose Infectious Diseases Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global In Vitro Assays to Diagnose Infectious Diseases Company Evaluation Quadrant
Table 14. Head Office of Key In Vitro Assays to Diagnose Infectious Diseases Player
Table 15. In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Type Footprint
Table 16. In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Application Footprint
Table 17. In Vitro Assays to Diagnose Infectious Diseases Mergers & Acquisitions Activity
Table 18. United States VS China In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China In Vitro Assays to Diagnose Infectious Diseases Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (States, Country)
Table 21. United States Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share (2018-2023)
Table 23. China Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (Province, Country)
Table 24. China Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share (2018-2023)
Table 26. Rest of World Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share (2018-2023)
Table 29. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2018-2023) & (USD Million)
Table 31. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2024-2029) & (USD Million)
Table 32. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2018-2023) & (USD Million)
Table 34. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2024-2029) & (USD Million)
Table 35. QIAGEN Basic Information, Area Served and Competitors
Table 36. QIAGEN Major Business
Table 37. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 38. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. QIAGEN Recent Developments/Updates
Table 40. QIAGEN Competitive Strengths & Weaknesses
Table 41. BD Basic Information, Area Served and Competitors
Table 42. BD Major Business
Table 43. BD In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 44. BD In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. BD Recent Developments/Updates
Table 46. BD Competitive Strengths & Weaknesses
Table 47. bioMerieux SA Basic Information, Area Served and Competitors
Table 48. bioMerieux SA Major Business
Table 49. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 50. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. bioMerieux SA Recent Developments/Updates
Table 52. bioMerieux SA Competitive Strengths & Weaknesses
Table 53. F. Hoffmann-La Roche, Ltd. Basic Information, Area Served and Competitors
Table 54. F. Hoffmann-La Roche, Ltd. Major Business
Table 55. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 56. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. F. Hoffmann-La Roche, Ltd. Recent Developments/Updates
Table 58. F. Hoffmann-La Roche, Ltd. Competitive Strengths & Weaknesses
Table 59. Hologic, Inc. (Gen-Probe) Basic Information, Area Served and Competitors
Table 60. Hologic, Inc. (Gen-Probe) Major Business
Table 61. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 62. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Hologic, Inc. (Gen-Probe) Recent Developments/Updates
Table 64. Hologic, Inc. (Gen-Probe) Competitive Strengths & Weaknesses
Table 65. Abbott Basic Information, Area Served and Competitors
Table 66. Abbott Major Business
Table 67. Abbott In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 68. Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Abbott Recent Developments/Updates
Table 70. Abbott Competitive Strengths & Weaknesses
Table 71. Quidel Corp.? Basic Information, Area Served and Competitors
Table 72. Quidel Corp.? Major Business
Table 73. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 74. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Quidel Corp.? Recent Developments/Updates
Table 76. Quidel Corp.? Competitive Strengths & Weaknesses
Table 77. iemens Healthineers AG Basic Information, Area Served and Competitors
Table 78. iemens Healthineers AG Major Business
Table 79. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 80. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. iemens Healthineers AG Recent Developments/Updates
Table 82. iemens Healthineers AG Competitive Strengths & Weaknesses
Table 83. Bio-Rad Laboratories, Inc. Basic Information, Area Served and Competitors
Table 84. Bio-Rad Laboratories, Inc. Major Business
Table 85. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 86. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 88. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 89. Danaher Corp. Basic Information, Area Served and Competitors
Table 90. Danaher Corp. Major Business
Table 91. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 92. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Danaher Corp. Recent Developments/Updates
Table 94. OraSure Technologies, Inc Basic Information, Area Served and Competitors
Table 95. OraSure Technologies, Inc Major Business
Table 96. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 97. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of In Vitro Assays to Diagnose Infectious Diseases Upstream (Raw Materials)
Table 99. In Vitro Assays to Diagnose Infectious Diseases Typical Customers
Table 1. World In Vitro Assays to Diagnose Infectious Diseases Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World In Vitro Assays to Diagnose Infectious Diseases Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World In Vitro Assays to Diagnose Infectious Diseases Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World In Vitro Assays to Diagnose Infectious Diseases Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key In Vitro Assays to Diagnose Infectious Diseases Players in 2022
Table 12. World In Vitro Assays to Diagnose Infectious Diseases Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global In Vitro Assays to Diagnose Infectious Diseases Company Evaluation Quadrant
Table 14. Head Office of Key In Vitro Assays to Diagnose Infectious Diseases Player
Table 15. In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Type Footprint
Table 16. In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Application Footprint
Table 17. In Vitro Assays to Diagnose Infectious Diseases Mergers & Acquisitions Activity
Table 18. United States VS China In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China In Vitro Assays to Diagnose Infectious Diseases Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (States, Country)
Table 21. United States Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share (2018-2023)
Table 23. China Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (Province, Country)
Table 24. China Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share (2018-2023)
Table 26. Rest of World Based In Vitro Assays to Diagnose Infectious Diseases Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share (2018-2023)
Table 29. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2018-2023) & (USD Million)
Table 31. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2024-2029) & (USD Million)
Table 32. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2018-2023) & (USD Million)
Table 34. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2024-2029) & (USD Million)
Table 35. QIAGEN Basic Information, Area Served and Competitors
Table 36. QIAGEN Major Business
Table 37. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 38. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. QIAGEN Recent Developments/Updates
Table 40. QIAGEN Competitive Strengths & Weaknesses
Table 41. BD Basic Information, Area Served and Competitors
Table 42. BD Major Business
Table 43. BD In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 44. BD In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. BD Recent Developments/Updates
Table 46. BD Competitive Strengths & Weaknesses
Table 47. bioMerieux SA Basic Information, Area Served and Competitors
Table 48. bioMerieux SA Major Business
Table 49. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 50. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. bioMerieux SA Recent Developments/Updates
Table 52. bioMerieux SA Competitive Strengths & Weaknesses
Table 53. F. Hoffmann-La Roche, Ltd. Basic Information, Area Served and Competitors
Table 54. F. Hoffmann-La Roche, Ltd. Major Business
Table 55. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 56. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. F. Hoffmann-La Roche, Ltd. Recent Developments/Updates
Table 58. F. Hoffmann-La Roche, Ltd. Competitive Strengths & Weaknesses
Table 59. Hologic, Inc. (Gen-Probe) Basic Information, Area Served and Competitors
Table 60. Hologic, Inc. (Gen-Probe) Major Business
Table 61. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 62. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Hologic, Inc. (Gen-Probe) Recent Developments/Updates
Table 64. Hologic, Inc. (Gen-Probe) Competitive Strengths & Weaknesses
Table 65. Abbott Basic Information, Area Served and Competitors
Table 66. Abbott Major Business
Table 67. Abbott In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 68. Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Abbott Recent Developments/Updates
Table 70. Abbott Competitive Strengths & Weaknesses
Table 71. Quidel Corp.? Basic Information, Area Served and Competitors
Table 72. Quidel Corp.? Major Business
Table 73. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 74. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Quidel Corp.? Recent Developments/Updates
Table 76. Quidel Corp.? Competitive Strengths & Weaknesses
Table 77. iemens Healthineers AG Basic Information, Area Served and Competitors
Table 78. iemens Healthineers AG Major Business
Table 79. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 80. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. iemens Healthineers AG Recent Developments/Updates
Table 82. iemens Healthineers AG Competitive Strengths & Weaknesses
Table 83. Bio-Rad Laboratories, Inc. Basic Information, Area Served and Competitors
Table 84. Bio-Rad Laboratories, Inc. Major Business
Table 85. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 86. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 88. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 89. Danaher Corp. Basic Information, Area Served and Competitors
Table 90. Danaher Corp. Major Business
Table 91. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 92. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Danaher Corp. Recent Developments/Updates
Table 94. OraSure Technologies, Inc Basic Information, Area Served and Competitors
Table 95. OraSure Technologies, Inc Major Business
Table 96. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product and Services
Table 97. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of In Vitro Assays to Diagnose Infectious Diseases Upstream (Raw Materials)
Table 99. In Vitro Assays to Diagnose Infectious Diseases Typical Customers
LIST OF FIGURES
Figure 1. In Vitro Assays to Diagnose Infectious Diseases Picture
Figure 2. World In Vitro Assays to Diagnose Infectious Diseases Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World In Vitro Assays to Diagnose Infectious Diseases Total Market Size (2018-2029) & (USD Million)
Figure 4. World In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 13. In Vitro Assays to Diagnose Infectious Diseases Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 16. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value Market Share by Region (2018-2029)
Figure 17. United States In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 18. China In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 23. India In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of In Vitro Assays to Diagnose Infectious Diseases by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for In Vitro Assays to Diagnose Infectious Diseases Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for In Vitro Assays to Diagnose Infectious Diseases Markets in 2022
Figure 27. United States VS China: In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: In Vitro Assays to Diagnose Infectious Diseases Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type in 2022
Figure 31. Immunoassay
Figure 32. Molecular Diagnosis
Figure 33. Others
Figure 34. World In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2018-2029)
Figure 35. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application in 2022
Figure 37. Streptococcus
Figure 38. Clostridium Difficile
Figure 39. Candida
Figure 40. Tuberculosis
Figure 41. Others
Figure 42. In Vitro Assays to Diagnose Infectious Diseases Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. In Vitro Assays to Diagnose Infectious Diseases Picture
Figure 2. World In Vitro Assays to Diagnose Infectious Diseases Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World In Vitro Assays to Diagnose Infectious Diseases Total Market Size (2018-2029) & (USD Million)
Figure 4. World In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company In Vitro Assays to Diagnose Infectious Diseases Revenue (2018-2029) & (USD Million)
Figure 13. In Vitro Assays to Diagnose Infectious Diseases Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 16. World In Vitro Assays to Diagnose Infectious Diseases Consumption Value Market Share by Region (2018-2029)
Figure 17. United States In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 18. China In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 23. India In Vitro Assays to Diagnose Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of In Vitro Assays to Diagnose Infectious Diseases by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for In Vitro Assays to Diagnose Infectious Diseases Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for In Vitro Assays to Diagnose Infectious Diseases Markets in 2022
Figure 27. United States VS China: In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: In Vitro Assays to Diagnose Infectious Diseases Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type in 2022
Figure 31. Immunoassay
Figure 32. Molecular Diagnosis
Figure 33. Others
Figure 34. World In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2018-2029)
Figure 35. World In Vitro Assays to Diagnose Infectious Diseases Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application in 2022
Figure 37. Streptococcus
Figure 38. Clostridium Difficile
Figure 39. Candida
Figure 40. Tuberculosis
Figure 41. Others
Figure 42. In Vitro Assays to Diagnose Infectious Diseases Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
